OAC
COCH icon

OMERS Administration Corp’s Envoy Medical COCH Stock Holding History

OMERS Administration Corp’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-69,999
Closed -$679K – 408
2021
Q3 		$679K Buy
+69,999
New +$678K 0.01% 142

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

OMERS Administration Corp's COCH Position: Q4 2021 in Review

OMERS Administration Corp sold out of Envoy Medical (COCH) in Q4 2021, closing a stake of 69,999 shares — an estimated $679K sold.

OMERS Administration Corp first reported a position in COCH in Q3 2021 and held it in 1 quarter. The position peaked at $679K in Q3 2021. 80 funds tracked by Wall St. Rank hold COCH as of Q4 2021.

  • OMERS Administration Corp reported no remaining Envoy Medical position as of Q4 2021 after selling out during the quarter.
  • OMERS Administration Corp sold 69,999 Envoy Medical shares in Q4 2021, an estimated $679K.
  • OMERS Administration Corp first reported a position in Envoy Medical in Q3 2021 and held it in 1 quarter.
  • OMERS Administration Corp's Envoy Medical position peaked at $679K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2021.

Based on OMERS Administration Corp's 13F filing for Q4 2021, filed 14 Feb 2022.